reference/22623255

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22623255

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, U.S. Gov't, Non-P.H.S.\|Research Support, U.S. Gov't, P.H.S.
endingPage	70
issn	0008-5472
issueIdentifier	5
pageRange	2062-70
publicationName	Cancer research
startingPage	2062
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6928aa1779309a3f087b3bfe94320b54 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c82a3ddc9a0c634c776e74b9cf1e0f52 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ffbe18712b8f4f9edb95eb50590bab6f
bibliographicCitation	Kirk CJ, Hartigan-O'Connor D, Nickoloff BJ, Chamberlain JS, Giedlin M, Aukerman L, Mule JJ. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. Cancer Res. 2001 Mar 01;61(5):2062–70. PMID: 11280767.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6ee0714fc690b96ffb06f7e7c7abc18 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a6d4d6dac38b68c36034b16efa500ee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11e443d0373703f7dde4173fb95ea49c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83f0e782d93929bb66274045344347b0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45e1bc1860bd683f3bc82fd99064e32f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3515a43f0dc2c2f868be23e72d0ed4c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e2bccfb1cce7128d2a5abd1caa6ae0d8
date	2001-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/11280767
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2786 https://portal.issn.org/resource/ISSN/0008-5472
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy
discusses	http://id.nlm.nih.gov/mesh/M0496688 http://id.nlm.nih.gov/mesh/M0029309 http://id.nlm.nih.gov/mesh/M0028294 http://id.nlm.nih.gov/mesh/M0285888
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D003713Q000276 http://id.nlm.nih.gov/mesh/D019742Q000276 http://id.nlm.nih.gov/mesh/D018414Q000276 http://id.nlm.nih.gov/mesh/D015496Q000276
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007111Q000187 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D019742Q000494 http://id.nlm.nih.gov/mesh/D019742Q000235 http://id.nlm.nih.gov/mesh/D015316 http://id.nlm.nih.gov/mesh/D018925Q000494 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D018925Q000276 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D007111Q000276 http://id.nlm.nih.gov/mesh/D008546Q000628 http://id.nlm.nih.gov/mesh/D008546Q000276 http://id.nlm.nih.gov/mesh/D015552 http://id.nlm.nih.gov/mesh/D054421 http://id.nlm.nih.gov/mesh/D018925Q000235 http://id.nlm.nih.gov/mesh/D016219 http://id.nlm.nih.gov/mesh/D003713Q000502 http://id.nlm.nih.gov/mesh/D051379
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cd2393f31310f3ecb571a1667afd88b1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8449

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368395

Total number of triples: 60.